Lupus anticoagulants: Pathogenesis and laboratory diagnosis

British Journal of Biomedical Science

Volumn 54, Issue 4, 1997, Pages 287-298

  Court, Emma L ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Antibodies, antiphospholipid; Antiphospholipid syndrome; Lupus coagulation inhibitor

Indexed keywords

ANTICOAGULANT AGENT; ECARIN; KAOLIN; LUPUS ANTICOAGULANT; SNAKE VENOM; TEXTARIN; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING TIME; HUMAN; LABORATORY DIAGNOSIS; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SNAKE; THROMBOSIS;

ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION TESTS; HUMANS; LUPUS COAGULATION INHIBITOR; THROMBOSIS;

EID: 0031468228     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (2)

1. Coots MC, Miller MA, Glueck HI. The lupus inhibitor: a study of its heterogeneity. Thromb Haemost 1981; 46(4):734-9.
2. Lafer EM, Rauch J, Andrzejewski C et al. Polyspecific monoclonal lupus autoantibodics reactive with both polynucleotides and phospholipids.J Exp Med 1981; 153:897-909.